focus -WSS

focus

author：entertainment 2025-09-05 05:54:16 - browse：397

Americans who suffer severe allergic reactions won’t have alternatives to auto-injectors like the EpiPen for a while longer. In a surprise move, the Food and Drug Administration on Tuesday declined to approve neffy, an epinephrine nasal spray. Instead, the FDA asked the drug’s manufacturer, ARS Pharma, to conduct further studies, specifically comparing the effect of repeat doses of epinephrine administered via nasal spray versus auto-injection in people with allergic rhinitis, or hay fever.

This was unexpected, and disappointing, for ARS Pharma: In May, an FDA advisory committee had voted 16-6 in favor of neffy’s approval for adults, and 17-5 in favor for children. But there is at least one party that’s likely to benefit from this development: Viatris, the maker of EpiPen, the brand-name epinephrine auto-injector used to treat anaphylaxis. (A generic version is also available, made by Teva).

In June, Viatris filed a citizen petition with the FDA, saying that the available evidence left doubts about how neffy would actually perform in a real-life anaphylactic event compared to auto-injectable epinephrine.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Hospitals owned by private equity see complications spike 25%

leisure time

WSS

Readout Newsletter: The latest on Moderna, Apellis, and Merck

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Virtual care provider acquires bankrupt Pear's prescription apps

Carvykti CAR

Scientists find bacteria from stomach of ancient iceman

Hospitals owned by private equity see complications spike 25%

knowledge

focus

hotspot

Sports medicine is finally prioritizing gender equality

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Hepatitis C has a cure — but many Americans still lack access to it

Slain Parkland victim's father speaks out following reenactment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medical mystery: When an infection after surgery isn’t what it seems

The high cost of giving birth even with insurance

Prosecutors seek bail revocation for FTX founder Sam Bankman

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Parkland mass shooting to be reenacted for lawsuit

knowledge

David Ricks of Eli Lilly: best biopharma CEO of 2023

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Rock icon Freddie Mercury pre

In Spain, a hospital brews its own CAR

SEC charges former device maker CEO with $41 million fraud

explore

leisure time

leisure time

Wikipedia